N-(1-(3-(2-fluoropropan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-4-yl)-6-((1-(methanesulfonyl)piperidin-4-yl)oxyl-N-(trifluoromethyl)pyrimidin-4-amine

ID: ALA4870635

PubChem CID: 164624288

Max Phase: Preclinical

Molecular Formula: C21H29F4N7O4S

Molecular Weight: 551.57

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(F)c1noc(N2CCC(N(c3cc(OC4CCN(S(C)(=O)=O)CC4)ncn3)C(F)(F)F)CC2)n1

Standard InChI:  InChI=1S/C21H29F4N7O4S/c1-20(2,22)18-28-19(36-29-18)30-8-4-14(5-9-30)32(21(23,24)25)16-12-17(27-13-26-16)35-15-6-10-31(11-7-15)37(3,33)34/h12-15H,4-11H2,1-3H3

Standard InChI Key:  NTGWXGVFVHJWLL-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 37 40  0  0  0  0  0  0  0  0999 V2000
   23.7929  -15.2368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3845  -15.9536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2095  -15.9490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5736  -13.3739    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.1613  -12.7904    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   12.3622  -12.5732    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.5293  -17.3289    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   17.8166  -16.9163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8155  -17.7398    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   16.1699  -15.0741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7170  -15.6879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5239  -15.5188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7814  -14.7339    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2258  -14.1179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4210  -14.2903    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.0744  -16.1335    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.8820  -15.9642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4308  -16.5845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2353  -16.4179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4966  -15.6348    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.9470  -15.0179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1360  -15.1842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3050  -15.4685    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0095  -17.0870    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   15.3627  -15.2451    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.8108  -14.6317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0707  -13.8513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5227  -13.2391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7143  -13.4062    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.4567  -14.1911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0075  -14.8091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4231  -12.0069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9163  -16.0226    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.6336  -15.6146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4673  -14.8064    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.6473  -14.7148    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.4661  -16.7765    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  5  4  2  0
  6  5  2  0
  8  7  1  0
  9  8  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 12 16  1  0
 16 17  1  0
 17 18  1  0
 17 22  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 20 23  1  0
 16  8  1  0
  8 24  1  0
 10 25  1  0
 25 26  1  0
 26 27  1  0
 26 31  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 29  5  1  0
  5 32  1  0
 23 33  2  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 23  1  0
 34  2  1  0
  2 37  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4870635

    ---

Associated Targets(Human)

GPR119 Tclin Glucose-dependent insulinotropic receptor (4762 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Gpr119 Glucose-dependent insulinotropic receptor (270 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 551.57Molecular Weight (Monoisotopic): 551.1938AlogP: 2.86#Rotatable Bonds: 7
Polar Surface Area: 117.79Molecular Species: NEUTRALHBA: 10HBD:
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 4.62CX LogP: 3.89CX LogD: 3.89
Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.38Np Likeness Score: -1.40

References

1. Kubo O, Takami K, Kamaura M, Watanabe K, Miyashita H, Abe S, Matsuda K, Tsujihata Y, Odani T, Iwasaki S, Kitazaki T, Murata T, Sato K..  (2021)  Discovery of a novel series of GPR119 agonists: Design, synthesis, and biological evaluation of N-(Piperidin-4-yl)-N-(trifluoromethyl)pyrimidin-4-amine derivatives.,  41  [PMID:34010766] [10.1016/j.bmc.2021.116208]

Source